NCT02571673 Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR) Status COMPLETED Phase N/A
NCT02563470 Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck Surgery Status COMPLETED Phase N/A
NCT02554968 Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer Status COMPLETED Phase N/A
NCT02544880 PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC Status COMPLETED Phase PHASE1
NCT02543645 A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer Status TERMINATED Phase PHASE1
NCT02526017 Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Status COMPLETED Phase PHASE1
NCT02517125 Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors Status COMPLETED Phase NA
NCT02516969 Surgery With or Without Adjuvant Stereotactic Body Radiotherapy Status COMPLETED Phase NA
NCT02507141 Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology Status RECRUITING Phase N/A
NCT02497573 Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer? Status UNKNOWN Phase N/A
NCT02489084 Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP) Status COMPLETED Phase N/A
NCT02475213 Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer Status COMPLETED Phase PHASE1
NCT02442739 Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers Status WITHDRAWN Phase EARLY_PHASE1
NCT02435576 Standard Follow-up Program (SFP) for Head and Neck Cancer Patients Status RECRUITING Phase N/A
NCT02433626 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies Status UNKNOWN Phase PHASE1
NCT02430298 Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients Status COMPLETED Phase PHASE2
NCT02423863 In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol® Status COMPLETED Phase PHASE2